Table 5 Clinical and pathological data of patients
Study ID | Clinical stage | Pathological stage | Gleason biopsy, n (%) | Gleason score, n (%) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cT1 | cT2 | cT3 | pT0 | pT1 | pT2 | pT3 | < 7 | 7 | > 7 | < 7 | 7 | > 7 | ||
Student [27], 2017 | T 32 | – | – | – | – | – | 20 (62.5) | 12 (37.5) | – | – | – | – | – | – |
N 34 | – | – | – | – | – | 23 (67.6) | 11 (32.4) | – | – | – | – | – | – | |
Liao [19], 2016 | T 82 | – | – | – | 3 (3.7) | 53 (64.6) | 26 (31.7) | 0 | – | – | – | 38 (46.3) | 32 (39.0) | 12 (14.6) |
N 79 | – | – | – | 2 (2.5) | 52 (65.8) | 22 (27.8) | 3 (3.8) | – | – | – | 27 (34.2) | 35 (44.3) | 17 (21.5) | |
Atug [25], 2012 | T 125 | – | – | – | – | 104 (82.9) | 19 (15.5) | 2 (1.6) | – | – | – | – | – | – |
N 120 | – | – | – | – | 100 (83.1) | 17 (14.4) | 3 (2.5) | – | – | – | – | – | – | |
Hoshi [10], 2014 | T 81 | 36 (44.4) | 40 (49.4) | 5 (6.2) | – | – | 68 (84.0) | 13 (16.0) | 29 (35.8) | 36 (44.4) | 16 (19.8) | 34 (42.0) | 35 (43.2) | 12 (14.8) |
N 47 | 30 (63.8) | 15 (31.9) | 2 (4.3) | – | – | 39 (83.0) | 8 (17.0) | 20 (42.6) | 21 (44.7) | 6 (12.8) | 15 (31.9) | 26 (55.3) | 6 (12.8) | |
Hurtes [20], 2012 | T 39 | – | – | – | 2 (5.1) | 29 (74.4) | 8 (20.5) | – | 24 (61.5) | 11 (28.2) | 4 (10.3) | 11 (28.2) | 26 (66.7) | 2 (5.1) |
N 33 | – | – | – | 0 | 24 (72.7) | 9 (27.3) | – | 18 (54.6) | 11 (33.3) | 4 (12.1) | 12 (36.4) | 18 (54.5) | 3 (9.1) | |
Tewari [18], 2007 | T 182 | 147 (80.8) | 30 (16.5) | 5 (2.7) | – | 146 (80.28) | 18.77 | 0.46 | – | – | – | – | – | – |
N 214 | 161 (75.2) | 51 (23.8) | 2 (0.9) | – | 186 (87.38) | 11.21 | 0.93 | – | – | – | – | – | – | |
Tan [26], 2010 | T 1383 | 1250 (90.4) | 133 (9.6) | 0 | – | 1147 (82.9) | 236 (17.1) | – | 828 (59.9) | 459 (33.2) | 96 (6.9) | 430 (31.1) | 874 (63.2) | 79 (5.7) |
N 214 | 161 (75.2) | 51 (23.8) | 2 (0.9) | – | 186 (86.9) | 28 (13.1) | – | 156 (72.9) | 48 (22.4) | 10 (4.7) | 102 (47.4) | 100 (46.9) | 12 (5.6) | |